JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

115.41

+1%↑

VEEV

160.84

+3.11%↑

JNJ

227.58

-1.32%↓

ABT

91.21

-1.32%↓

MDT

83.38

-0.41%↓

115.41

+1%↑

VEEV

160.84

+3.11%↑

Начало・Списък с акции・Odonate Therapeutics Inc

O
Odonate Therapeutics Inc

Затворен

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

Максимум

Odonate Therapeutics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

24.04.2026 г., 00:00 ч. UTC

Печалби

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

24.04.2026 г., 00:00 ч. UTC

Печалби

Renesas Electronics 1Q Net Y68.15B Vs Net Y26.01B

23.04.2026 г., 23:47 ч. UTC

Пазарно говорене

Gold Edges Lower Amid Ongoing Concerns Over Higher Inflation -- Market Talk

23.04.2026 г., 23:43 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

23.04.2026 г., 23:43 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

23.04.2026 г., 23:43 ч. UTC

Пазарно говорене

Nikkei May Decline Amid Uncertainty Over U.S.-Iran Conflict -- Market Talk

23.04.2026 г., 23:13 ч. UTC

Придобивния, сливания и поглъщания

Trump on Spirit Airlines: 'I Think We'd Just Buy It' -- Update

23.04.2026 г., 22:33 ч. UTC

Печалби

Intel Shares Jump 20% as AI Agents Drive Big Growth -- WSJ

23.04.2026 г., 22:17 ч. UTC

Печалби

PLS Executed Offtake Agreement With Ronbay

23.04.2026 г., 22:17 ч. UTC

Печалби

PLS Secured Up to A$38.1M in Australia Government ARENA Grant Funding

23.04.2026 г., 22:16 ч. UTC

Печалби

PLS Commences Commissioning of Midstream Demonstration Plant

23.04.2026 г., 22:15 ч. UTC

Печалби

PLS Group Reaffirms FY26 Guidance for All Metrics

23.04.2026 г., 22:14 ч. UTC

Печалби

PLS Group 3Q Cash Margin From Operations A$461M at March 31

23.04.2026 г., 22:14 ч. UTC

Печалби

PLS Group 3Q Cash Balance A$1.455 Billion at March 31

23.04.2026 г., 22:13 ч. UTC

Печалби

PLS Group 3Q Unit Operating Cost A$733/Ton CIF, Up 2% on 2Q

23.04.2026 г., 22:12 ч. UTC

Печалби

Correct: PLS Group 3Q Unit Operating Cost A$520/Ton FOB, Down 11% on 2Q

23.04.2026 г., 22:12 ч. UTC

Печалби

PLS Group 3Q Unit Operating Cost US$520/Ton FOB, Down 11% on 2Q

23.04.2026 г., 22:11 ч. UTC

Печалби

PLS Group 3Q Realized Price US$1,867/Ton, Up 61% on 2Q

23.04.2026 г., 22:10 ч. UTC

Печалби

PLS Group 3Q Revenue A$567,000, Up 52% on 2Q

23.04.2026 г., 22:09 ч. UTC

Печалби

PLS Group 3Q Sales 195,700 Tons, Down 16% on 2Q

23.04.2026 г., 22:08 ч. UTC

Печалби

PLS Group 3Q Production 232,400 Tons, Up 12% on 2Q

23.04.2026 г., 22:04 ч. UTC

Печалби

Intel Sales Rise 7% as AI Agents Drive Growth -- WSJ

23.04.2026 г., 21:56 ч. UTC

Пазарно говорене

Печалби

Intel Points to Growing Role of CPUs Amid AI Shifts -- Market Talk

23.04.2026 г., 21:48 ч. UTC

Придобивния, сливания и поглъщания

Regeneron Shares Up on Trump Drug Pricing Deal -- Barrons.com

23.04.2026 г., 21:27 ч. UTC

Печалби

Intel CFO: All Demand Signals Point to Growing Role of CPUs in AI Era

23.04.2026 г., 21:25 ч. UTC

Печалби

Intel CFO Expects Factories to Continue Increasing Supply in 3Q, 4Q, but at More Measured Pace Than Previously Expected

23.04.2026 г., 21:24 ч. UTC

Печалби

SAP Stock Rebounds From Software Slaughter. The Cloud Boosted Europe's Tech Titan. -- Barrons.com

23.04.2026 г., 21:24 ч. UTC

Печалби

Blackstone Stock Falls After Earnings. Private Credit Remains in Focus. -- Barrons.com

23.04.2026 г., 21:21 ч. UTC

Печалби

Intel to Look for Unconventional Way to Boost Manufacturing Capacity Through Musk's Terafab Project, CEO Says

23.04.2026 г., 21:21 ч. UTC

Печалби

Intel CEO: He, Elon Musk Believe Global Semiconductor Supply Isn't Keeping Up With Accelerating Demand

Сравнение с други в отрасъла

Ценова промяна

Odonate Therapeutics Inc Прогноза

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

EBITDA

Оперативна печалба

Относно Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.